National Institute of Agronomical Research, Clermont-Ferrand, France.
Am J Clin Nutr. 2010 Jun;91(6):1716-24. doi: 10.3945/ajcn.2009.28666. Epub 2010 Apr 14.
Prospective studies indicate that tomato consumers are protected against prostate cancer. Lycopene has been hypothesized to be responsible for tomato health benefits.
Our aim was to differentiate the effects of tomato matrix from those of lycopene by using lycopene-rich red tomatoes, lycopene-free yellow tomatoes, and purified lycopene.
Thirty healthy men (aged 50-70 y old) were randomly assigned to 2 groups after a 2-wk washout period. In a crossover design, each group consumed yellow and red tomato paste (200 g/d, which provided 0 and 16 mg lycopene, respectively) as part of their regular diet for 1 wk separated by 2 wk of washout. Then, in a parallel design, the first group underwent supplementation with purified lycopene (16 mg/d) for 1 wk, whereas the second group received a placebo. Sera collected before and after the interventions were incubated with lymph node cancer prostate cells to measure the expression of 45 target genes.
Circulating lycopene concentration increased only after consumption of red tomato paste and purified lycopene. Lipid profile, antioxidant status, prostate-specific antigen, and insulin-like growth factor I were not modified by consumption of tomato pastes and lycopene. We observed significant up-regulation of IGFBP-3 and Bax:Bcl-2 ratio and down-regulation of cyclin-D1, p53, and Nrf-2 after cell incubation with sera from men who consumed red tomato paste when compared with sera collected after the first washout period, with intermediate values for yellow tomato paste consumption. Cell incubation with sera from men who consumed purified lycopene led to significant up-regulation of IGFBP-3, c-fos, and uPAR compared with sera collected after placebo consumption.
Dietary lycopene can affect gene expression whether or not it is included in its food matrix. This trial was registered by the French Health Ministry at http://www.sante-sports.gouv.fr as 2006-A00396-45.
前瞻性研究表明,番茄消费者可预防前列腺癌。类胡萝卜素已被假设为番茄健康益处的原因。
我们的目的是通过使用富含番茄红素的红番茄、不含番茄红素的黄番茄和纯化的番茄红素来区分番茄基质和番茄红素的作用。
30 名健康男性(年龄 50-70 岁)在 2 周洗脱期后随机分为 2 组。在交叉设计中,每组在正常饮食中分别摄入黄番茄酱和红番茄酱(分别提供 0 和 16 毫克番茄红素,每天 200 克),为期 1 周,洗脱期为 2 周。然后,在平行设计中,第一组接受纯化的番茄红素(16 毫克/天)补充 1 周,而第二组接受安慰剂。在干预前后收集的血清与淋巴结前列腺癌细胞孵育,以测量 45 个靶基因的表达。
仅在食用红番茄酱和纯化的番茄红素后,循环中的番茄红素浓度才增加。食用番茄酱和番茄红素不会改变血脂谱、抗氧化状态、前列腺特异性抗原和胰岛素样生长因子 I。与第一次洗脱期后收集的血清相比,用食用红番茄酱后男性的血清孵育细胞后,观察到 IGFBP-3 和 Bax:Bcl-2 比值的显著上调,以及 cyclin-D1、p53 和 Nrf-2 的下调,而食用黄番茄酱的血清则出现中间值。用食用纯化的番茄红素后男性的血清孵育细胞导致 IGFBP-3、c-fos 和 uPAR 的显著上调,与安慰剂相比。
无论是否包含在其食物基质中,膳食番茄红素都可以影响基因表达。这项试验是由法国卫生部在 http://www.sante-sports.gouv.fr 注册的,注册号为 2006-A00396-45。